Fatal cardiac arrhythmia after oral sumatriptan - PubMed

Case Reports

Fatal cardiac arrhythmia after oral sumatriptan

K Laine et al. Headache. 1999 Jul-Aug.

Abstract

Typically, 3% to 5% of patients experience sensations of heaviness, pressure, and tightness in the chest after administration of sumatriptan, but there is little ECG evidence of ischemia. The serious cardiovascular incidents after consuming sumatriptan have been associated mostly with the subcutaneous dosage form of this drug and with patients with underlying cardiovascular risk factors. We report a case of fatal cardiac arrhythmia in an otherwise perfectly healthy patient with migraine after consuming a single 100-mg dose of oral sumatriptan.

Comment in

• Migraine, eating disorders, and triptans: an unrecognized risk?

  Wilkinson F. Wilkinson F. Headache. 2001 Oct;41(9):914-5. Headache. 2001. PMID: 11703486 No abstract available.

Similar articles

• The clinical profile of sumatriptan: safety and tolerability.

  Lloyd K. Lloyd K. Eur Neurol. 1994;34 Suppl 2:40-3. doi: 10.1159/000119531. Eur Neurol. 1994. PMID: 7835382 Review.

• [Use of sumatriptan (Imigran) in a female patient with coronary spasm].

  Peters RH, Meyburg HW, Westendorp PH, Westerhof PW. Peters RH, et al. Ned Tijdschr Geneeskd. 1994 Sep 10;138(37):1872-4. Ned Tijdschr Geneeskd. 1994. PMID: 7935925 Dutch.

• [Treatment of migraine attacks with sumatriptan].

  Pfaffenrath V. Pfaffenrath V. Fortschr Med. 1993 Oct 20;111(29):465-8. Fortschr Med. 1993. PMID: 8258424 Review. German.

• Vasospasm-induced myocardial infarction with sumatriptan.

  Mueller L, Gallagher RM, Ciervo CA. Mueller L, et al. Headache. 1996 May;36(5):329-31. doi: 10.1046/j.1526-4610.1996.3605329.x. Headache. 1996. PMID: 8682677

Cited by

• Chemical mediators of migraine: preclinical and clinical observations.

  Gupta S, Nahas SJ, Peterlin BL. Gupta S, et al. Headache. 2011 Jun;51(6):1029-45. doi: 10.1111/j.1526-4610.2011.01929.x. Headache. 2011. PMID: 21631491 Free PMC article. Review.

• 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?

  Neeb L, Meents J, Reuter U. Neeb L, et al. Neurotherapeutics. 2010 Apr;7(2):176-82. doi: 10.1016/j.nurt.2010.03.003. Neurotherapeutics. 2010. PMID: 20430316 Free PMC article. Review.

• The Effect of Sumatriptan in Ischemic Conditions in the Rat Heart.

  Altunkaynak-Çamca HÖ, Tecder-Ünal M, Tuncer M. Altunkaynak-Çamca HÖ, et al. Turk J Pharm Sci. 2018 Dec;15(3):328-332. doi: 10.4274/tjps.03371. Epub 2018 Nov 20. Turk J Pharm Sci. 2018. PMID: 32454677 Free PMC article.

• Vasospasm induced myocardial ischaemia secondary to sumatriptan use.

  Okonkwo K, Ojha U. Okonkwo K, et al. BMJ Case Rep. 2020 Aug 24;13(8):e235387. doi: 10.1136/bcr-2020-235387. BMJ Case Rep. 2020. PMID: 32843411 Free PMC article.

• The pharmacological management of migraine, part 1: overview and abortive therapy.

  Demaagd G. Demaagd G. P T. 2008 Jul;33(7):404-16. P T. 2008. PMID: 19750119 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Medical

  • MedlinePlus Health Information